EPICYPHER, INC.
EpiCypher
DURHAM, United States · Founded 2015 · $3.4M raised
- Headquarters
- DURHAM, North Carolina
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- epicypher.com
- Total Funding
- $3.4M
- Last Round
- $3.3M SeedJun 2024
- Rounds
- 3
About
EpiCypher is a Durham, NC-based epigenetics company and global leader in recombinant nucleosome manufacturing, founded in 2012 by leading chromatin biology researchers. The company develops CUTANA genomic mapping assays, designer nucleosomes, and epigenetics reagents and services used by academic and biopharma researchers to advance chromatin biology and drug development.
Summary
EPICYPHER, INC. is a Biotech company based in DURHAM, United States, founded in 2015. It has raised $3.4M in total across 3 rounds, most recently a $3.3M Seed round in Jun 2024.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...